Contract Pharma Features Cryoport Growth and Innovation

June 23, 2020

A new Contract Pharma article is all about Cryoport!

The author interviews Mark Sawicki, Chief Commercial Officer and Phil Wilson, Senior Vice President of Global Operations & Supply Chain, who discusses the company's rapid growth alongside the growing cell and gene therapy market, how the global pandemic of COVID-19 is affecting our clients from both a clinical and commercial standpoint, and how we're providing innovative new services, including the first and only validated cleaning and disinfection process in the life sciences industry, Veri-Clean™.

Contract Pharma concludes: "Simply put, without them [Cryoport], new cell and gene therapies can't be developed, or more importantly, delivered to the patients who need them most."

Read the full article here.

Tags: Temperature Controlled Logistics, cold chain shipping, transportation, Cryoport News, Biopharma Industry News